Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview.

Journal of acquired immune deficiency syndromes (1999) - 1 Mar 2006

Bartlett John A, Buda Jeffrey J, von Scheele Birgitta, Mauskopf Josephine A, Davis E Anne, Elston Robert, King Martin S, Lanier E Randall

Abstract excerpt

OBJECTIVE: To identify optimal first-line therapies based on the rate of virologic success (VS) and the preservation of future treatment options in antiretroviral therapy (ART)-naive subjects. DESIGN: Systematic overview of genotypic resistance mutations from clinical trials of combination ART. M...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Meta-Analysis as Topic

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 16540933
DOI: 10.1097/01.qai.0000197070.69859.f3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16540933-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview.PMID 16540933Read ↗

HIV-1 drug-resistance patterns among patients on failing treatment in a large number of European countries.Semantic proximity Read ↗

Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy.Semantic proximity Read ↗

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome.Semantic proximity Read ↗

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptaseSemantic proximity Read ↗

Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients.Semantic proximity Read ↗

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.Semantic proximity Read ↗

Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy--implications for sustained efficacy of ART in resource-limited settings.Semantic proximity Read ↗

Avoiding Drug Resistance in HIV Reverse Transcriptase.Semantic proximity Read ↗

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase.Semantic proximity Read ↗

Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited SettingsSemantic proximity Read ↗

Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128).Semantic proximity Read ↗

Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.